The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. (Q48187138)

9 February 2018

title

The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. (English)

1 reference

9 February 2018

0 references

0 references

B H Westerink

1

1 reference

9 February 2018

J Tuntler

2

1 reference

9 February 2018

G Damsma

3

1 reference

9 February 2018

H Rollema

4

1 reference

9 February 2018

J B de Vries

5

1 reference

9 February 2018

publication date

1 November 1987

1 reference

9 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

9 February 2018

volume

336

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

502-507

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00169306

exact match

0 references

cites work

On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.

1 reference

12 December 2020

Amino acids in rat striatal dialysates: methodological aspects and changes after electroconvulsive shock.

1 reference

12 December 2020

Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid

1 reference

12 December 2020

Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-per

1 reference

12 December 2020

Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.

1 reference

12 December 2020

Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis

1 reference

12 December 2020

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

1 reference

12 December 2020

The use of in vivo brain dialysis of dopamine, acetylcholine, amino acids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

12 December 2020

Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

1 reference

12 December 2020

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

1 reference

12 December 2020

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

1 reference

12 December 2020

Chemicals as tools in the study of excitable membranes

1 reference

12 December 2020

Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

1 reference

12 December 2020

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

12 December 2020

Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity

1 reference

12 December 2020

Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.

1 reference

12 December 2020

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

1 reference

12 December 2020

Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron

1 reference

12 December 2020

Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores

1 reference

12 December 2020

Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.

1 reference

12 December 2020

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

1 reference

12 December 2020

Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00169306

1 reference

9 February 2018

PubMed ID

3501841

1 reference

9 February 2018